Non-HDL Cholesterol as a Practical Gatekeeper for Adolescent Dyslipidemia Screening: Implications for Nutrition and Public Health
Nutrients · 13.07.2026 · 18 (14) · 2285
DOI: 10.3390/nu18142285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 13.07.2026. Verfasst von Kazufumi Nakamura und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan. Hauptthemen laut MEDLINE: Cholesterol, Dyslipidemias, Mass Screening, Public Health. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dyslipidemia in adolescents represents an early and potentially modifiable stage in the lifelong trajectory of cardiovascular disease. However, optimal lipid screening strategies in this age group remain controversial, particularly regarding feasibility, biological relevance, and reliance on family history. Non-high-density lipoprotein cholesterol (non-HDL cholesterol) has emerged as a promising screening marker because it reflects the total burden of atherogenic lipoproteins and can be reliably assessed even without fasting, making it particularly suitable for large-scale pediatric screening settings. A recent nationwide population-based study of Korean adolescents provides robust real-world evidence supporting the utility of non-HDL cholesterol in dyslipidemia screening, across both sexes and independent of familial lipid risk. From a nutritional and public health perspective, non-HDL cholesterol is closely related to dietary habits, postprandial hyperlipidemia, and metabolic stress, and is particularly important in the modern food environment characterized by increased consumption of ultra-processed foods. This Opinion discusses the biological rationale, clinical feasibility, and population-level implications of non-HDL cholesterol-based screening in adolescents. By linking lipid biology with nutrition-focused prevention and lifelong cardiovascular health, non-HDL cholesterol may serve as a practical gatekeeper for early risk identification and upstream intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan.
ORCID-Profile: Kazufumi Nakamura, Taiji Okada, Hiroshi Kawahara, Takahiro Sakamoto, Junya Tanabe, Akihiro Endo
Zitieren
APA
Nakamura, K., Okada, T., Watanabe, N., Sato, H., Kagawa, Y., Kawahara, H., Sakamoto, T., Yamasaki, S., Tanabe, J., Furuta, M., Kawanami, Y., Miki, Y., & Endo, A. (2026). Non-HDL Cholesterol as a Practical Gatekeeper for Adolescent Dyslipidemia Screening: Implications for Nutrition and Public Health. Nutrients, 18(14), 2285. https://doi.org/10.3390/nu18142285
Vancouver
Nakamura K, Okada T, Watanabe N, Sato H, Kagawa Y, Kawahara H, et al. Non-HDL Cholesterol as a Practical Gatekeeper for Adolescent Dyslipidemia Screening: Implications for Nutrition and Public Health. Nutrients. 2026;18(14):2285. doi:10.3390/nu18142285
BibTeX
@article{Nakamura2026,
author = {Nakamura, Kazufumi and Okada, Taiji and Watanabe, Nobuhide and Sato, Hirotomo and Kagawa, Yuzo and Kawahara, Hiroshi and Sakamoto, Takahiro and Yamasaki, Seita and Tanabe, Junya and Furuta, Madoka and Kawanami, Yuka and Miki, Yuko and Endo, Akihiro},
title = {Non-HDL Cholesterol as a Practical Gatekeeper for Adolescent Dyslipidemia Screening: Implications for Nutrition and Public Health},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {14},
pages = {2285},
doi = {10.3390/nu18142285}
}
EUVIMED